Standard-dose gentamicin does not increase risk of patent ductus arteriosus
Background: Rates of patent ductus arteriosus (PDA) and infection are high in preterm infants. Preterm infants with infection are more likely to develop symptomatic PDA, a potentially fatal disease. Clinically, gentamicin is widely used for early-onset infection in neonates including preterm infants...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020-02-01
|
| Edice: | Pediatrics and Neonatology |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S1875957218307502 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
